For Employers

MENARINI Group

Senior Director, Global Regulatory Affairs

Posted 26 minutes ago
$264K - $319K per year
10+ years experience
Apply Now

Please mention DailyRemote when applying

?Not checked yet0100
Resume Match Score

See how much of this job your resume covers, and what’s missing.

Want a recruiter to go through it line by line?

Get professional review

Tailor your resume to this job

One click makes a copy of your resume for this role, scores it against the posting, and proposes edits line by line. Your default resume is never changed.

  • Job match score for this posting
  • Edits you accept or skip, no invented facts
  • Download it when it reads right: TXT free, PDF with Premium

Create a cover letter for this job

Upload your resume and we draft a letter for this exact role, tailored to what it asks for.

  • Tailored to this role
  • Based on your resume
  • Fully editable
AI Summary

The Senior Director of Global Regulatory Affairs serves as the Global Regulatory Lead, driving regulatory strategy for oncology products and ensuring alignment with business priorities. They are responsible for managing interactions with health authorities like the FDA and EMA, overseeing global dossier planning, and mentoring junior team members.

Company:

0750 Stemline Therapeutics Inc

Contract Type:

Permanent

Join us in shaping the future of Menarini - with passion, integrity, and a deep commitment to people.

 

About Menarini Group - Menarini is a leading international biopharmaceutical company committed to advancing health through innovation, research, and quality. For more than 135 years, we have worked to improve patients’ lives across a broad range of therapeutic areas through our dedication to science, integrity, and care for people. With a strong foundation in scientific excellence and a purpose-driven culture, Menarini offers diverse career opportunities for professionals eager to make a meaningful impact on global health.


Position Title:  Senior Director, Global Regulatory Affairs


Reports To:  Vice President, Regulatory Affairs


Overview:


The Senior Director of Global Regulatory Affairs Oncology is a leader in the Global Regulatory Affairs Oncology department and is a key contributor to the successful development of Stemline/Menarini’s pipeline. He/She, as a Global Regulatory Lead (GRL), is responsible to create and drive the Global Regulatory strategy for a product/projects) and ensure there is a robust regulatory foundation for the successful optimization of the product / project(s) in accordance with business priorities working closely with local and regional stakeholders (e.g., medical, marketing, market access) to ensure alignment on global strategy. Accountable for evaluating regulatory risks and opportunities throughout product development and lifecycle management, including assessment of probability of regulatory success and development of risk mitigation strategies. Responsible for driving global dossier planning, core labeling strategy, and alignment of regulatory objectives with business priorities. All regulatory activities will be conducted keeping oncology patients in mind; meaning, he/she will keep abreast with US/EU regulations, key Health Authority guidance, regulatory precedents, and assess opportunities for leveraging expedited development pathways/regulatory mechanisms.

In this role, the Senior Director may be required to interact with key Regulatory Agencies. The assigned programs may have different levels of complexity with more than one indication, formulation, or external business partner.  The Senior Director may also be assigned specific project and/or department responsibilities and may have one or more direct reports.  He/she will be part of an international environment and is expected to actively contribute to developing the network and expanding the knowledge of the GRA Oncology team, including the mentoring of junior colleagues.


Responsibilities: 


  • Global Strategy Lead for regulatory implementation.
  • May be the primary RA representative and responsible to their region in relation to overall project strategy including pre-clinical and clinical (working with local RA where required).
  • Responsible for the Global regulatory strategy and ensuring alignment with Global commercial plans and priorities to optimize portfolio.
  • Accountable for identifying, assessing, and communicating regulatory risks, opportunities, and mitigation plans to senior leadership, enabling informed portfolio and development decisions.
  • Designs, coordinates, directs, and conducts all global regulatory interactions, including United States Food and Drug Administration (FDA) and European Medicines Agency (EMA) interactions and other competent health authorities, leading preparation for agency meetings/interactions, health authority responses and labeling negotiations as appropriate.
  • Responsible for regulatory interactions, and submissions, including development of global regulatory submission strategies, integrated dossier planning, core prescribing information and strategic accountability for the regional filings while leveraging their GRT subject matter experts and endorsed by GRT.
  • Trains, acts as mentor and ensures proactive communication and knowledge sharing of strategic regulatory topics with GRT and other relevant stakeholders.
  • Acts as subject matter expert, as applicable.
  • Challenges and improves existing procedures.
  • Reviews relevant documents that will be included in regional /global regulatory applications/interactions in accordance with local and global regulatory guidance/legislation, as applicable, while leveraging GRT subject matter expertise.
  • Manages coordination, preparation and timely submission and approval of various original and variation filings (e.g., INDs/CTAs, MAAs, NDAS/BLAs) for their region, working in a global collaborative manner. Ensures timely follow up and execution according to agreed timelines.
  • Maintains expert knowledge of regional and global regulatory requirements, ICH guidance, regulatory precedents, and emerging health authority expectations along with familiarity with FDA/EMA/key international market regulations including Competitor intelligence/landscape.
  • Provides clear and valid regulatory guidance, interpretation by applying 'out of the box thinking' mindset, direction to GRT and region of responsibility.
  • Acts pro-actively and sustains a good stakeholder collaboration within GRA via continuous stakeholder management.
  • Represents GRA according to delegated tasks.

Qualifications:


  • Science based B.S. with requisite experience and demonstrated capability. Advanced degree (M.S.,PhD, PharmD) preferred.
  • Minimum 10 years of relevant Regulatory Affairs experience, with increasing responsibility demonstrated in previous roles.  
  • Experience in an Oncology therapeutic area.
  • Demonstrated Leadership skills in a complex matrix environment.
  • Demonstrated people management skills.
  • Proven track record of Global Regulatory Lead with successful leadership of marketing applications and approvals (across US and EU),bringing new oncology products to registration.
  • Demonstrated experience in regulatory risk assessment, scenario planning, and development of regulatory mitigation strategies for complex development programs.
  • Prior experience in leading teams in the development and execution submissions including INDs, CTAs, BLAs, NDAs, MAAs.
  • Regulatory Lead and expert knowledge in or more major regions (US/EU preferred).
  • Demonstrated experience in Japan/China/RoW.
    Exceptional interpersonal skills with the ability to work in a global environment, individually as well in multi-disciplinary team, and with external partners and regulators.
  • Ability to generate innovative solutions to complex regulatory problems and effectively work with and communicate with key stakeholders.
  • Proven ability to consistently deliver within defined timelines, cost, and quality standards.
  • Direct experience of interfacing with relevant regulatory authorities.
  • Comfortable working in a matrix environment to achieve team goals and desired outcomes. 
  • Experience managing relationships with contractors and CROs is preferred.

Preferred:

  • Global Oncology Drug Development
  • IND/CTA/NDA/BLA/MAA experience (Oncology)
  • Regulatory risk assessment
  • Due diligences
  • Precision medicine/CDx
  • People Management

****US - Remote-based candidates will be considered****


Please note: This position is classified as a corporate office position. In accordance with the New York state employer convenience rule, Stemline will withhold New York state income taxes for all corporate office employees, regardless of whether these employees work in New York or remotely.

Base Salary Range of $264,846 - 319,073.  Menarini Stemline offers generous compensation and benefits packages, including, Fidelity 401(k) (with company match), PPO and HDHP insurance plans, Company paid Basic Life & AD&D insurance and pre-tax FSA/HSA programs.

Menarini Stemline is committed to creating an inclusive environment for all employees.  All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran. Reasonable accommodations may be made to enable qualified individuals with disabilities to perform the essential functions.  To request an accommodation, please contact hrus@menarinistemline. com prior to your interview.

#LI-Remote


Base Salary Range of:

264846

Menarini Stemline offers generous compensation and benefits packages, including Fidelity 401(k) (with company match), Healthcare insurance, Company-paid Basic Life & AD&D insurance and pre-tax FSA/HSA programs.


Menarini Stemline is committed to creating an inclusive environment for all employees. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran. Reasonable accommodations may be made to enable qualified individuals with disabilities to perform the essential functions.


The Company


Founded in 1886 in Naples under the name of Farmacia Internazionale, Menarini moved in 1915 to Florence where the Group’s headquarters are still located today. High quality therapeutics and diagnostics solutions for patients, ethics as our underlying principle, dedication to innovation and advancement, strong people centricity and environmental sustainability. These five pillars form the foundation of the Menarini Group, an Italian pharmaceutical company with nearly 135 years of history. 

 

The Menarini Group is present in 70 countries and our products are sold in 140 locations around the world. Its companies span from Europe to Asia, to Africa and the Middle East, to Central America and to the United States where with the acquisition of Stemline Therapeutics, a NASDAQ-listed biopharmaceutical company, the company marked its entry into the US oncology market.

 

Thanks to the valuable contribution of around 18,000 employees, every year more than 500 million packs of drugs are produced at the Group's 18 manufacturing sites including a biotech plant for the manufacturing of monoclonal antibodies that also serves external clients distributed across 6 continents.


Menarini has made a strong commitment to oncology, investing in a pipeline of five investigational compounds for the treatment of a variety of haematological and solid tumours. The acquisition of Stemline Therapeutics in June 2020, further strengthened Menarini’s oncology portfolio, adding both commercial and clinical-stage assets. Tagraxofusp is a novel, first in class targeted therapy for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) and to date, the only approved treatment for BPDCN in the U.S. and EU, and the first and only approved CD123-targeted therapy. Tagraxofusp is also being evaluated as both a single agent and in combination, in other CD123+ indications, including acute myeloid leukaemia (AML), chronic myelomonocytic leukaemia (CMML), and myelofibrosis (MF). 


Additionally, Menarini received exclusive rights to commercialise Selinexor for the treatment of oncology indications in the European Union and other European countries (including the United Kingdom), Latin America and other key countries. Menarini has signed an exclusive licensing agreement with Karyopharm Therapeutics for the rights to commercialise an innovative therapeutic option in Europe, Latin America, Turkey, Russia, and CIS countries. Selinexor is a first-in-class, oral Selective Inhibitor of Nuclear export compound for the treatment of hematologic cancers and solid tumours. It is already marketed in the US for multiple myeloma and is under development for solid tumour indications. Selinexor is registered in the EU for both early and late lines.


Menarini entered into a global licence agreement with Radius Health to complete the development of Elacestrant, an oral SERD in late-stage Phase 3 development for hormone receptor-positive advanced breast cancer. Following a successful phase 3 study, Menarini Stemline received FDA approval in January 2023 under priority review and successfully oversaw a strong launch in February to the US market with the EMA review process concluded positively in September 2023. 


Menarini’s commitment to oncology is also reflected in the investments made in the liquid biopsy diagnostic field through its affiliate Menarini Silicon Biosystems (MSB), a pioneer in rare cell analysis and non-invasive, advanced diagnostic solutions. MSB’s CELLSEARCH Circulating Tumour Cell (CTC) Test is the first and only clinically validated blood test cleared by the U.S. Food & Drug Administration (FDA) for detecting and counting CTCs in metastatic breast, prostate, and colorectal cancer when used in conjunction with other clinical monitoring methods.


Since 2021, MSB has offered in the US a menu of non-invasive Laboratory Developed Tests (LDTs) provided through its CLIA/CAP accredited US-based Lab. The services include CMC enumeration, CTC enumeration and PDL-1/HER2 biomarker and offer a minimally invasive approach to follow cancer patient’s therapeutic journey. 


In 2022, the company launched the CELLSEARCH® Circulating Multiple Myeloma Cell (CMMC) Enumeration LDT, the first-of-its-kind, which directly measures levels of plasma cells in the blood of patients. This test provides new, complementary information to that of the bone marrow biopsy and other standard-of-care measures. Due to its minimally invasive nature, it can be performed serially to assess plasma cell burden without requiring repeated bone marrow biopsies.

 

Menarini's vision and uniqueness in oncology is to bring together innovative therapeutic solutions and advanced liquid biopsy-based diagnostics for faster, more effective and precise patient management. 


It is an exciting time in the company’s development and an excellent opportunity for individuals joining us to contribute to building and shaping Menarini Stemline's Oncology business.


For more details on how we handle your data, please refer to our Privacy Policy.

Automatically Apply to the Best Remote Jobs

Stop the endless job search. Our AI finds and applies to the best jobs for you.

Try it Now
Keep looking

Similar Jobs

See all Remote Legal jobs →

FSP Contract Specialist

Full Time Chile Legal

Asia Legal Campaigner

Freelance United States $40 - $50 per hour Legal

Enterprise Director - Pharmacy Regulatory and Compliance

Full Time United States Legal

Director, EHS Regulatory - Water and Wastewater Treatment Design

Full Time United States $140K - $182K per year Legal

Compliance Officer - Australia

Full Time Australia Legal

Veterans Legal and Human Rights Expert, Remote- Contract

Freelance United States $50 - $100 per hour Legal
Apply Now

Personalize your Remote Job Search in 3 Easy Steps!

Featuring 219,445+ Jobs in Legal

Answer easy questions

Answer easy questions

219,445+ jobs across 15+ categories

Get your best job matches

Get your best job matches

Only hand-screened, legit jobs

Find a remote job faster

Find a remote job faster

No ads, scams, or junk

“I was the first applicant for a remote marketing position that got listed on the company website the same day I applied. Had an interview within 48 hours!”

Sarah J. — Sarah J. · Marketing Manager ★★★★★ Verified